Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper

Stefania La Grutta, Bousquet, Todo Bom, Fokkens, Gianenrico Senna, Bousquet, Giorgio Walter Canonica, Maurer, Terreehorst, Brzoza, Pinto, Erminia Ridolo, Ilaria Baiardini, Stefania La Grutta, Zuberbier, Alessandro Fiocchi, Carlo Lombardi, Gerth Van Wijk, Compalati, Fulvio Braido

    Risultato della ricerca: Article

    49 Citazioni (Scopus)

    Abstract

    The GA(2)LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore the available tools to provide criteria for a proper choice, identify patient-related factor which could influence PROs assessment, define specific recommendations for assessment, analysis and results spreading, underline the unexplored areas and unmet needs. PROs assessment is gaining increasing importance, and it must be performed with a rigorous methodological procedure and using validated tools. This approach enables to better understand patient-related factors influencing clinical trials and real-life management outcomes, identify patients subgroups that can benefit from specific treatment and management plan and tailor treatment to address PROs (not only physician-defined targets) to improve asthma and rhinitis management.
    Lingua originaleEnglish
    pagine (da-a)959-968
    Numero di pagine10
    RivistaALLERGY
    Volume65
    Stato di pubblicazionePublished - 2010

    Fingerprint

    Asthma
    Quality of Life
    Rhinitis
    Patient Outcome Assessment
    Clinical Trials
    Hypersensitivity
    Allergic Rhinitis
    Patient Reported Outcome Measures
    Physicians
    Therapeutics
    Research

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology

    Cita questo

    Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. / La Grutta, Stefania; Bousquet; Todo Bom; Fokkens; Senna, Gianenrico; Bousquet; Canonica, Giorgio Walter; Maurer; Terreehorst; Brzoza; Pinto; Ridolo, Erminia; Baiardini, Ilaria; La Grutta, Stefania; Zuberbier; Fiocchi, Alessandro; Lombardi, Carlo; Gerth Van Wijk; Compalati; Braido, Fulvio.

    In: ALLERGY, Vol. 65, 2010, pag. 959-968.

    Risultato della ricerca: Article

    La Grutta, S, Bousquet, Todo Bom, Fokkens, Senna, G, Bousquet, Canonica, GW, Maurer, Terreehorst, Brzoza, Pinto, Ridolo, E, Baiardini, I, La Grutta, S, Zuberbier, Fiocchi, A, Lombardi, C, Gerth Van Wijk, Compalati & Braido, F 2010, 'Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper', ALLERGY, vol. 65, pagg. 959-968.
    La Grutta, Stefania ; Bousquet ; Todo Bom ; Fokkens ; Senna, Gianenrico ; Bousquet ; Canonica, Giorgio Walter ; Maurer ; Terreehorst ; Brzoza ; Pinto ; Ridolo, Erminia ; Baiardini, Ilaria ; La Grutta, Stefania ; Zuberbier ; Fiocchi, Alessandro ; Lombardi, Carlo ; Gerth Van Wijk ; Compalati ; Braido, Fulvio. / Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. In: ALLERGY. 2010 ; Vol. 65. pagg. 959-968.
    @article{c78da607165447c3ac8599c9384a74af,
    title = "Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper",
    abstract = "The GA(2)LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore the available tools to provide criteria for a proper choice, identify patient-related factor which could influence PROs assessment, define specific recommendations for assessment, analysis and results spreading, underline the unexplored areas and unmet needs. PROs assessment is gaining increasing importance, and it must be performed with a rigorous methodological procedure and using validated tools. This approach enables to better understand patient-related factors influencing clinical trials and real-life management outcomes, identify patients subgroups that can benefit from specific treatment and management plan and tailor treatment to address PROs (not only physician-defined targets) to improve asthma and rhinitis management.",
    author = "{La Grutta}, Stefania and Bousquet and {Todo Bom} and Fokkens and Gianenrico Senna and Bousquet and Canonica, {Giorgio Walter} and Maurer and Terreehorst and Brzoza and Pinto and Erminia Ridolo and Ilaria Baiardini and {La Grutta}, Stefania and Zuberbier and Alessandro Fiocchi and Carlo Lombardi and {Gerth Van Wijk} and Compalati and Fulvio Braido",
    year = "2010",
    language = "English",
    volume = "65",
    pages = "959--968",
    journal = "Allergy: European Journal of Allergy and Clinical Immunology",
    issn = "0105-4538",
    publisher = "Wiley-Blackwell Publishing Ltd",

    }

    TY - JOUR

    T1 - Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper

    AU - La Grutta, Stefania

    AU - Bousquet, null

    AU - Todo Bom, null

    AU - Fokkens, null

    AU - Senna, Gianenrico

    AU - Bousquet, null

    AU - Canonica, Giorgio Walter

    AU - Maurer, null

    AU - Terreehorst, null

    AU - Brzoza, null

    AU - Pinto, null

    AU - Ridolo, Erminia

    AU - Baiardini, Ilaria

    AU - La Grutta, Stefania

    AU - Zuberbier, null

    AU - Fiocchi, Alessandro

    AU - Lombardi, Carlo

    AU - Gerth Van Wijk, null

    AU - Compalati, null

    AU - Braido, Fulvio

    PY - 2010

    Y1 - 2010

    N2 - The GA(2)LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore the available tools to provide criteria for a proper choice, identify patient-related factor which could influence PROs assessment, define specific recommendations for assessment, analysis and results spreading, underline the unexplored areas and unmet needs. PROs assessment is gaining increasing importance, and it must be performed with a rigorous methodological procedure and using validated tools. This approach enables to better understand patient-related factors influencing clinical trials and real-life management outcomes, identify patients subgroups that can benefit from specific treatment and management plan and tailor treatment to address PROs (not only physician-defined targets) to improve asthma and rhinitis management.

    AB - The GA(2)LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore the available tools to provide criteria for a proper choice, identify patient-related factor which could influence PROs assessment, define specific recommendations for assessment, analysis and results spreading, underline the unexplored areas and unmet needs. PROs assessment is gaining increasing importance, and it must be performed with a rigorous methodological procedure and using validated tools. This approach enables to better understand patient-related factors influencing clinical trials and real-life management outcomes, identify patients subgroups that can benefit from specific treatment and management plan and tailor treatment to address PROs (not only physician-defined targets) to improve asthma and rhinitis management.

    UR - http://hdl.handle.net/10447/102871

    M3 - Article

    VL - 65

    SP - 959

    EP - 968

    JO - Allergy: European Journal of Allergy and Clinical Immunology

    JF - Allergy: European Journal of Allergy and Clinical Immunology

    SN - 0105-4538

    ER -